EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis

Hillary S Hayden, Maria T Nelson, Sydney E Ross, Adrian J Verster, Drake C Bouzek, Alex Eng, Adam Waalkes, Kelsi Penewit, Benjamin T Kopp, Christopher Siracusa, Michael J Rock, Stephen J Salipante und 2 weitere

Pediatric Pulmonology · 2025

DOI: 10.1002/ppul.71024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, 2025. Verfasst von Hillary S Hayden und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Feces, Anti-Bacterial Agents, Oropharynx. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, This work was supported by the Cystic Fibrosis Foundation (CFF; SANDER16Y5, SANDER18A0-I) and the National Institutes of Health (NIH; NIH NHLBI K24HL141669)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Systemic antibiotics can impact all microbes inhabiting patients, regardless of the intended target organism(s). We studied the simultaneous effects on respiratory and fecal microbiomes of β‐lactam antibiotics administered for respiratory symptoms in infants with cystic fibrosis (IWCF).

Objective

To compare the magnitude and duration of intended (respiratory) and unintended (fecal) antimicrobial action by analyzing oropharyngeal (OP) and fecal microbiota in IWCF.

Design

Shotgun metagenomic sequencing and qPCR were performed on OP and fecal samples collected longitudinally from 14 IWCF (ages 1–17 months) during (“On Antibiotics”) and after (“Off Antibiotics”) β‐lactam therapy, and from 5 IWCF (3–16 months) never treated with antibiotics.

Results

Total bacterial loads (TBL) for On Antibiotics samples were lower than for both Never (OP and fecal) and Off Antibiotics samples (fecal only). α‐diversities (within‐sample) for OP On Antibiotics samples were lower than for Never and Off Antibiotics samples but did not differ between fecal sample groups. β‐diversity (between‐sample) differed between all OP sample groups and between fecal On and Never Antibiotics and Off and Never antibiotics samples; however, fecal On and Off Antibiotics sample β‐diversities did not differ. Patterns of change in antibiotic resistance gene abundances reflected shifts in microbial community composition. Conclusions β‐lactam antibiotic exposure was followed by marked alterations in both OP and fecal microbiota. While microbiota appeared to rebound after treatment in both sample types, our results suggest that fecal microbiota recovered less than OP. The clinical consequences of these findings should be studied in IWCF and other populations frequently treated with antibiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisFecesAnti-Bacterial AgentsOropharynxMicrobiotabeta-LactamsHumansInfantMaleFemaleBacterial LoadLongitudinal Studies

Stichwörter der Autor:innen

antibiotic resistancemetagenomerespiratory symptoms

Substanzen

Anti-Bacterial Agentsbeta-Lactams

Autor:innen und Institutionen

  • Department of Pediatrics, University of Washington, Seattle, Washington, USA.
  • Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Pythia Informatics, Ottawa, Canada.
  • Department of Microbiology, University of Washington, Seattle, Washington, USA.
  • Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
  • Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • This work was supported by the Cystic Fibrosis Foundation (CFF; SANDER16Y5, SANDER18A0-I) and the National Institutes of Health (NIH; NIH NHLBI K24HL141669).

Zitieren

APA

Hayden, H. S., Nelson, M. T., Ross, S. E., Verster, A. J., Bouzek, D. C., Eng, A., Waalkes, A., Penewit, K., Kopp, B. T., Siracusa, C., Rock, M. J., Salipante, S. J., Hoffman, L. R., & Sanders, D. B. (2025). Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71024

Vancouver

Hayden HS, Nelson MT, Ross SE, Verster AJ, Bouzek DC, Eng A, et al. Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71024

BibTeX
@article{Hayden2025,
  author = {Hayden, Hillary S and Nelson, Maria T and Ross, Sydney E and Verster, Adrian J and Bouzek, Drake C and Eng, Alex and Waalkes, Adam and Penewit, Kelsi and Kopp, Benjamin T and Siracusa, Christopher and Rock, Michael J and Salipante, Stephen J and Hoffman, Lucas R and Sanders, Don B},
  title = {Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis},
  journal = {Pediatric Pulmonology},
  year = {2025},
  doi = {10.1002/ppul.71024}
}
Kostenlos starten →